Real-World Use of Molecular Testing for Endometrial Cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study examines how hospitals in Italy use molecular testing (genetic analysis) to better classify and treat endometrial cancer. It may help doctors personalize treatment based on the cancer's molecular characteristics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You work at or are treated at an Italian hospital involved in endometrial cancer care
- The hospital participates in surgical treatment of endometrial cancer
- Your hospital is willing to participate in the study and share data
- You have been diagnosed with endometrial cancer (cancer of the uterine lining)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This study uses two simple tests (a cell sample from the uterus and a cervical DNA test) to find endometrial cancer early and to check how well fertility-sparing treatment is working.
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
This study looks at the specific type of endometrial cancer (endometrioid) in Mexican patients to understand how different molecular features affect prognosis. It may help doctors better tailor treatment to the individual.
This study looks at how well a surgical tool is used during standard surgery for early endometrial cancer, and whether it relates to test results from fluid taken in the abdomen. It may help surgeons improve how samples are collected and interpreted during routine care.
This trial tests whether a blood test for ctDNA (cancer DNA fragments) can help doctors decide if standard chemotherapy plus an immunotherapy drug is working for people with advanced or recurrent endometrial cancer. It may help tailor your treatment based on how the cancer responds.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.